TYPE 2 DIABETES (T2DM)

This study compares a new magnetic surgery that connects parts of the intestine to a common diabetes medication (semaglutide) for controlling obesity and type 2 diabetes. About 20 adults with a BMI of 30-40 and type 2 diabetes will be randomly assigned to one of the two treatment…

This study tests a new medicine called BGM0504 against a well-known drug, semaglutide, in people with type 2 diabetes. All participants take metformin and then receive either BGM0504 or semaglutide once a week. The main goal is to see which drug lowers blood sugar more after 24 w…

This study tests whether a new daily pill (obicetrapib, alone or combined with ezetimibe) can lower bad cholesterol more than a placebo in 300 adults with type 2 diabetes or metabolic syndrome who are already on standard cholesterol treatment. Participants take the study drug for…

This study tests whether personalized marketing and discounts in an online grocery store can encourage people with prediabetes or type 2 diabetes to buy more whole grains instead of refined grains. About 216 adults aged 45-70 from Pennsylvania who already shop online for grocerie…

This study will check how common hypercortisolism (too much cortisol) is in 500 adults with type 2 diabetes that is hard to control despite standard treatments. Researchers will also see if cortisol levels in saliva are linked to blood sugar control. The goal is to better underst…

This study looks at how the body responds to glucagon, a hormone that helps control blood sugar and fat burning, in people with type 2 diabetes. Researchers want to see if glucagon resistance is linked to fatty liver disease and heart problems. About 24 adults with type 2 diabete…

This study compares cinematic virtual reality (VR) to traditional lectures for teaching medical students how to care for older adults with complex health needs. About 100 medical students will participate, with some using VR to experience realistic patient scenarios. Researchers …

This study looks at whether sexual activity increases the risk of low blood sugar (hypoglycemia) in adults with type 1 or type 2 diabetes who use insulin and a continuous glucose monitor (CGM). One hundred participants will mark sexual activity in their CGM app for 3 months. Rese…

This study will follow 1000 adults in Hong Kong who have both type 2 diabetes and a common liver condition called MASLD (fatty liver disease). Researchers want to understand how these two conditions interact over time and what factors predict serious outcomes like liver scarring …